ArticleThe Journal of experimental medicine2021

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma.

Catalina Lee-Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.